BigBear.ai Holdings Inc(NYSE:BBAI) 
BigBear.ai Holdings, Inc. provides artificial intelligence-powered decision intelligence solutions. It offers national security, supply chain management, and digital identity and biometrics solutions. The company also provides data ingestion, data enrichment, data processing, artificial intelligence...
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues | 34,435,000 | 27,300,000 | 33,143,000 | 32,472,000 | 34,757,000 | 43,827,000 | 41,505,000 | 39,783,000 | 33,121,000 | 40,563,000 | 33,988,000 | 38,459,000 | 42,154,000 | 40,357,000 | 40,651,000 | 37,613,000 | 36,390,000 | |||||
yoy | -0.93% | -37.71% | -20.15% | -18.38% | 4.94% | 8.05% | 22.12% | 3.44% | -21.43% | 0.51% | -16.39% | 2.25% | 15.84% | NaN% | NaN% | NaN% | ||||||
qoq | 26.14% | -17.63% | 2.07% | -6.57% | -20.70% | 5.59% | 4.33% | 20.11% | -18.35% | 19.35% | -11.63% | -8.77% | 4.45% | -0.72% | 8.08% | 3.36% | NaN% | NaN% | ||||
cost of revenues | 22,714,000 | 21,752,000 | 25,714,000 | 24,359,000 | 27,369,000 | 27,422,000 | 30,739,000 | 28,720,000 | 26,135,000 | 27,547,000 | 25,579,000 | 29,496,000 | 31,941,000 | 28,572,000 | 28,900,000 | 28,023,000 | 26,523,000 | |||||
gross margin | 11,721,000 | 5,548,000 | 7,429,000 | 8,113,000 | 7,388,000 | 16,405,000 | 10,766,000 | 11,063,000 | 6,986,000 | 13,016,000 | 8,409,000 | 8,963,000 | 10,213,000 | 11,785,000 | 11,751,000 | 9,590,000 | 9,867,000 | |||||
yoy | 58.65% | -66.18% | -31.00% | -26.67% | 5.75% | 26.04% | 28.03% | 23.43% | -31.60% | 10.45% | -28.44% | -6.54% | 3.51% | |||||||||
qoq | 111.27% | -25.32% | -8.43% | 9.81% | -54.96% | 52.38% | -2.68% | 58.36% | -46.33% | 54.79% | -6.18% | -12.24% | -13.34% | 0.29% | 22.53% | -2.81% | ||||||
gross margin % | 34.04% | 20.32% | 22.41% | 24.98% | 21.26% | 37.43% | 25.94% | 27.81% | 21.09% | 32.09% | 24.74% | 23.31% | 24.23% | 29.20% | 28.91% | 25.50% | 27.11% | NaN% | NaN% | NaN% | NaN% | |
operating expenses: | ||||||||||||||||||||||
selling, general and administrative | 29,225,000 | 25,658,000 | 25,255,000 | 21,487,000 | 22,732,000 | 22,243,000 | 17,485,000 | 23,364,000 | 16,948,000 | 18,232,000 | 15,533,000 | 16,930,000 | 20,362,000 | 15,570,000 | 20,233,000 | 26,952,000 | 22,020,000 | |||||
research and development | 5,533,000 | 4,818,000 | 3,375,000 | 4,393,000 | 4,166,000 | 2,334,000 | 3,820,000 | 3,565,000 | 1,144,000 | 2,031,000 | -349,000 | 2,225,000 | 1,128,000 | 1,199,000 | 1,785,000 | 2,535,000 | 2,874,000 | |||||
restructuring charges | 113,000 | 660,000 | 1,899,000 | 1,698,000 | -30,000 | 457,000 | 860,000 | 42,000 | 25,000 | 755,000 | 2,641,000 | 1,562,000 | ||||||||||
transaction expenses | 1,218,000 | 347,000 | 1,103,000 | 1,284,000 | 1,437,000 | 454,000 | 566,000 | 186,000 | 1,399,000 | |||||||||||||
operating income | -24,255,000 | -80,526,000 | -21,861,000 | -90,302,000 | -21,208,000 | -8,142,000 | -10,539,000 | -16,670,000 | -98,069,000 | -8,573,000 | -8,212,000 | -10,217,000 | -12,032,000 | -26,371,000 | -12,395,000 | -55,335,000 | -16,426,000 | |||||
yoy | 14.37% | 889.02% | 107.43% | 441.70% | -78.37% | -5.03% | 28.34% | 63.16% | 715.07% | -67.49% | -33.75% | -81.54% | -26.75% | |||||||||
qoq | -69.88% | 268.35% | -75.79% | 325.79% | 160.48% | -22.74% | -36.78% | -83.00% | 1043.93% | 4.40% | -19.62% | -15.08% | -54.37% | 112.76% | -77.60% | 236.87% | ||||||
operating margin % | -70.44% | -294.97% | -65.96% | -278.09% | -61.02% | -18.58% | -25.39% | -41.90% | -296.09% | -21.14% | -24.16% | -26.57% | -28.54% | -65.34% | -30.49% | -147.12% | -45.14% | NaN% | NaN% | NaN% | NaN% | |
interest expense | 317,000 | 3,977,000 | 4,604,000 | 4,419,000 | 5,116,000 | 15,000,000 | 3,541,000 | 3,551,000 | 3,555,000 | 3,544,000 | 3,540,000 | 3,560,000 | 3,556,000 | 3,770,000 | 3,557,000 | 3,554,000 | 3,555,000 | |||||
interest income | -3,785,000 | |||||||||||||||||||||
net increase in fair value of derivatives | 20,125,000 | -50,168,000 | -26,125,000 | 135,751,000 | 33,336,000 | 92,826,000 | -1,278,000 | -7,882,000 | 23,992,000 | 3,121,000 | 10,567,000 | |||||||||||
loss on extinguishment of debt | 15,826,000 | 2,577,000 | ||||||||||||||||||||
other expense | 11,000 | -306,000 | -87,000 | 7,000 | 8,000 | -26,000 | 30,000 | |||||||||||||||
loss before taxes | -56,749,000 | -228,605,000 | -61,961,000 | -11,722,000 | -125,161,000 | -16,898,000 | -26,155,000 | -23,317,500 | -15,858,000 | -58,664,000 | -18,748,000 | |||||||||||
income tax expense | 14,000 | 14,000 | 17,000 | 14,000 | 25,000 | 5,500 | 21,000 | 15,000 | -14,000 | 50,000 | -5,000 | -3,000 | 59,000 | -226,000 | 252,000 | 77,000 | ||||||
net income | -56,763,000 | -5,830,000 | 2,521,000 | -228,619,000 | -61,986,000 | -146,487,000 | -12,176,000 | -11,737,000 | -125,147,000 | -21,256,000 | 3,999,000 | -16,895,000 | -26,214,000 | -29,895,000 | -16,110,000 | -56,844,000 | -18,825,000 | |||||
yoy | -8.43% | -96.02% | -120.70% | 1847.85% | -50.47% | 589.16% | -404.48% | -30.53% | 377.41% | -28.90% | -124.82% | -70.28% | 39.25% | |||||||||
qoq | 873.64% | -331.26% | -101.10% | 268.82% | -57.68% | 1103.08% | 3.74% | -90.62% | 488.76% | -631.53% | -123.67% | -35.55% | -12.31% | 85.57% | -71.66% | 201.96% | ||||||
net income margin % | -164.84% | -21.36% | 7.61% | -704.05% | -178.34% | -334.24% | -29.34% | -29.50% | -377.85% | -52.40% | 11.77% | -43.93% | -62.19% | -74.08% | -39.63% | -151.13% | -51.73% | NaN% | NaN% | NaN% | NaN% | |
basic net loss per share | -0.12 | -0.71 | -0.25 | -0.05 | -0.67 | -0.12 | -0.19 | -0.23 | -0.13 | -0.45 | -0.14 | |||||||||||
diluted net loss per share | -0.12 | 0.05 | -0.03 | -0.71 | -0.25 | -0.05 | -0.67 | -0.12 | -0.19 | -0.23 | -0.13 | -0.45 | -0.14 | |||||||||
weighted-average shares outstanding: | ||||||||||||||||||||||
basic | 473,059,547 | 358,801,375 | 396,589,354 | 320,591,204 | 252,341,401 | 233,604,500 | 249,951,542 | 246,303,139 | 187,279,204 | 149,234,917 | 155,830,775 | 145,469,043 | 138,548,599 | 127,698,478 | 126,270,282 | 126,223,903 | 131,882,556 | 107,009,834 | ||||
diluted | 473,059,547 | 358,801,375 | 448,158,249 | 320,591,204 | 252,341,401 | 233,604,500 | 249,951,542 | 246,303,139 | 187,279,204 | 149,234,917 | 157,894,001 | 145,469,043 | 138,548,599 | 127,698,478 | 126,270,282 | 126,223,903 | 131,882,556 | 107,009,834 | ||||
other comprehensive income | ||||||||||||||||||||||
change in unrealized gains and losses on available-for-sale securities | ||||||||||||||||||||||
unrealized losses on afs investments, net of tax expense | -818 | |||||||||||||||||||||
foreign currency translation | 118 | -22 | -45 | -282 | 12 | 129 | -8 | |||||||||||||||
total other comprehensive income | -700 | 12 | ||||||||||||||||||||
total comprehensive loss | -57,463 | -228,901 | -61,974 | |||||||||||||||||||
goodwill impairment | 70,636,000 | 85,000,000 | 18,292,000 | 35,252,000 | ||||||||||||||||||
other income | -1,255,250 | -2,878,000 | -1,867,000 | -276,000 | -429,750 | -647,000 | -617,000 | -455,000 | 8,247.25 | 32,989 | -207,845 | -22,117 | ||||||||||
income before taxes | -72,007,000 | 2,538,000 | -37,259,500 | -12,155,000 | -9,764,750 | 3,994,000 | ||||||||||||||||
basic net income per share | -0.218 | 0.01 | -0.163 | -0.05 | -0.068 | 0.03 | ||||||||||||||||
total other comprehensive loss | -78.75 | -45 | -282 | -2 | -8 | |||||||||||||||||
total comprehensive income | -72,099.75 | 2,476 | -37,267 | -12,184 | ||||||||||||||||||
other comprehensive loss | ||||||||||||||||||||||
diluted net income per share | -0.163 | -0.05 | -0.068 | 0.03 | ||||||||||||||||||
net decrease in fair value of derivatives | -492,750 | -15,659,000 | -391,000 | -102,000 | -199,000 | -1,263,000 | ||||||||||||||||
income tax benefit | -1,820,000 | |||||||||||||||||||||
general and administrative expenses | 491,054.5 | 1,964,218 | 1,537,939 | 595,106 | ||||||||||||||||||
income from operations | -491,054.5 | -1,964,218 | -1,537,939 | -595,106 | ||||||||||||||||||
interest income on cash and marketable securities held in trust account | 2,261.25 | 9,045 | 6,194 | 4,921 | ||||||||||||||||||
income before provision for income taxes | -480,546 | -1,922,184 | ||||||||||||||||||||
provision for income taxes | 674.75 | 2,699 | ||||||||||||||||||||
net loss and comprehensive loss | -481,220.75 | -1,924,883 | ||||||||||||||||||||
net income attributable to common stock subject to possible redemption | 1,586.5 | 6,346 | ||||||||||||||||||||
basic and diluted weighted-average shares outstanding, common stock subject to possible redemption | 35,880,000 | |||||||||||||||||||||
basic and diluted net income per share, common stock subject to possible redemption | ||||||||||||||||||||||
net loss attributable to non-redeemable common stock | -482,807.25 | -1,931,229 | ||||||||||||||||||||
weighted-average non-redeemable common shares outstanding, basic and diluted | 10,051,600 | |||||||||||||||||||||
net income per share | -0.048 | -0.19 | -0.15 | -0.06 | ||||||||||||||||||
income before benefit from income taxes | -1,739,590 | -612,302 | ||||||||||||||||||||
benefit from income taxes | 1,849 | 1,468 | ||||||||||||||||||||
net income and comprehensive loss | -1,741,439 | -613,770 | ||||||||||||||||||||
net income attributable to common stockholders | -1,744,671 | |||||||||||||||||||||
weighted-average common shares outstanding, basic and diluted | 11,662,811 | 10,375,485 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||
current assets: | ||||||||||||||||||||||
cash and cash equivalents | 100,704,000 | 87,126,000 | 456,580,000 | 390,845,000 | 107,610,000 | 50,141,000 | 65,584,000 | 72,266,000 | 81,412,000 | 32,557,000 | 32,184,000 | 29,923,000 | 21,827,000 | 12,632,000 | 21,955,000 | 29,829,000 | 59,978,000 | 68,900,000 | ||||
restricted cash | 6,002,000 | 5,521,000 | 101,021,000 | |||||||||||||||||||
available for sale investments, at fair value | 248,682,000 | 200,461,000 | ||||||||||||||||||||
accounts receivables | 22,807,000 | 22,703,000 | 24,371,000 | 28,342,000 | 34,565,000 | 38,953,000 | 32,464,000 | 33,944,000 | 36,584,000 | 21,949,000 | 29,030,000 | 36,269,000 | 32,678,000 | 30,091,000 | 31,652,000 | 28,546,000 | 26,624,000 | 28,605,000 | ||||
contract assets | 874,000 | 218,000 | 2,180,000 | 701,000 | 512,000 | 895,000 | 1,914,000 | 1,041,000 | 2,379,000 | 4,822,000 | 452,000 | 346,000 | 2,427,000 | 1,312,000 | 1,323,000 | 1,252,000 | 2,934,000 | 628,000 | ||||
prepaid expenses and other current assets | 14,946,000 | 14,514,000 | 6,546,000 | 4,395,000 | 5,547,000 | 3,768,000 | 4,222,000 | 4,519,000 | 4,661,000 | 4,449,000 | 4,104,000 | 5,042,000 | 8,775,000 | 10,300,000 | 5,084,000 | 8,097,000 | 6,601,000 | 7,028,000 | ||||
total current assets | 394,015,000 | 330,543,000 | 619,761,000 | 424,283,000 | 148,234,000 | 93,757,000 | 104,184,000 | 111,770,000 | 125,036,000 | 63,777,000 | 65,770,000 | 71,580,000 | 65,707,000 | 54,335,000 | 60,014,000 | 67,724,000 | 96,137,000 | 206,182,000 | 1,331,165 | 2,021,884 | 2,985,747 | |
non-current assets: | ||||||||||||||||||||||
property and equipment | 1,736,000 | 1,562,000 | 1,439,000 | 1,425,000 | 1,454,000 | 1,566,000 | 1,519,000 | 1,586,000 | 1,570,000 | 997,000 | 1,095,000 | 1,199,000 | 1,308,000 | 1,433,000 | 1,528,000 | 1,433,000 | 1,335,000 | 1,078,000 | ||||
goodwill | 238,737,000 | 241,100,000 | 48,446,000 | 48,446,000 | 119,081,000 | 119,081,000 | 118,621,000 | 118,621,000 | 119,769,000 | 48,683,000 | 48,683,000 | 48,683,000 | 48,683,000 | 48,683,000 | 67,125,000 | 67,164,000 | 91,636,000 | 91,636,000 | ||||
intangible assets | 137,421,000 | 139,470,000 | 112,670,000 | 115,621,000 | 117,600,000 | 119,119,000 | 119,257,000 | 118,197,000 | 120,444,000 | 82,040,000 | 82,823,000 | 81,948,000 | 83,816,000 | 85,685,000 | 87,551,000 | 89,456,000 | 81,976,000 | 83,646,000 | ||||
right-of-use assets | 6,830,000 | 7,063,000 | 7,309,000 | 8,639,000 | 8,893,000 | 9,263,000 | 9,430,000 | 9,620,000 | 9,701,000 | 4,041,000 | 4,188,000 | 4,341,000 | 4,491,000 | 4,638,000 | ||||||||
other non-current assets | 859,000 | 860,000 | 1,351,000 | 958,000 | 1,006,000 | 990,000 | 1,072,000 | 1,089,000 | 1,107,000 | 372,000 | 452,000 | 469,000 | 509,000 | 483,000 | 692,000 | 727,000 | 741,000 | 780,000 | ||||
total assets | 861,664,000 | 894,547,000 | 919,756,000 | 599,372,000 | 396,268,000 | 343,776,000 | 354,083,000 | 360,883,000 | 377,627,000 | 199,910,000 | 203,011,000 | 208,220,000 | 204,565,000 | 195,308,000 | 216,910,000 | 226,504,000 | 271,825,000 | 383,322,000 | 360,265,812 | 361,027,362 | 361,790,668 | 380,653 |
liabilities and stockholders’ equity | ||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||
accounts payable | 4,234,000 | 6,088,000 | 5,577,000 | 3,440,000 | 3,936,000 | 8,455,000 | 4,249,000 | 7,128,000 | 6,215,000 | 11,038,000 | 9,076,000 | 7,298,000 | 10,508,000 | 15,422,000 | 7,426,000 | 6,354,000 | 6,625,000 | 5,475,000 | 26,471 | 34,593 | 50,628 | 34,395 |
current portion of long-term debt | 16,601,000 | |||||||||||||||||||||
accrued liabilities | 15,568,000 | 19,649,000 | 18,299,000 | 16,555,000 | 20,734,000 | 19,496,000 | 26,356,000 | 20,375,000 | 21,516,000 | 16,233,000 | 15,460,000 | 15,630,000 | 18,271,000 | 13,366,000 | 17,494,000 | 15,978,000 | 17,042,000 | 10,735,000 | 2,312,049 | 1,124,417 | 362,745 | 230,333 |
contract liabilities | 11,272,000 | 14,756,000 | 3,507,000 | 4,466,000 | 3,017,000 | 2,541,000 | 2,082,000 | 3,496,000 | 3,853,000 | 879,000 | 2,320,000 | 2,000,000 | 2,347,000 | 2,022,000 | 4,758,000 | 3,714,000 | 2,792,000 | 4,207,000 | ||||
current portion of long-term lease liability | 1,013,000 | 1,095,000 | 1,073,000 | 1,096,000 | 1,091,000 | 1,068,000 | 1,075,000 | 1,077,000 | 848,000 | 779,000 | 803,000 | 850,000 | 810,000 | 806,000 | ||||||||
derivative liabilities | 9,982,000 | 116,906,000 | 167,075,000 | 193,199,000 | 57,449,000 | 170,515,000 | 15,796,000 | 17,074,000 | 24,956,000 | 37,862,000 | 28,467,000 | 44,126,000 | 25,469,000 | 44,827,000 | ||||||||
other current liabilities | 6,094,000 | 10,466,000 | 2,392,000 | 2,522,000 | 2,070,000 | 73,000 | 1,027,000 | 3,748,000 | 4,856,000 | 602,000 | 871,000 | 1,355,000 | 2,136,000 | 2,085,000 | 2,290,000 | 881,000 | 623,000 | 541,000 | 6,016 | 3,317 | 1,468 | |
total current liabilities | 64,764,000 | 185,520,000 | 197,923,000 | 221,645,000 | 89,115,000 | 202,966,000 | 50,585,000 | 53,315,000 | 63,070,000 | 68,622,000 | 56,997,000 | 71,781,000 | 60,837,000 | 35,760,000 | 32,737,000 | 28,848,000 | 30,156,000 | 70,018,000 | 2,401,926 | 1,205,604 | 435,316 | |
non-current liabilities: | ||||||||||||||||||||||
long-term debt | 90,484,000 | 104,852,000 | 102,683,000 | 100,588,000 | 135,404,000 | 195,738,000 | 195,250,000 | 194,761,000 | 194,273,000 | 193,784,000 | 193,296,000 | 192,807,000 | 192,318,000 | 191,830,000 | 191,341,000 | 190,853,000 | 190,364,000 | |||||
long-term lease liability | 6,495,000 | 6,673,000 | 6,965,000 | 8,494,000 | 8,770,000 | 9,120,000 | 9,327,000 | 9,562,000 | 11,300,000 | 4,313,000 | 4,517,000 | 4,714,000 | 4,906,000 | 5,092,000 | ||||||||
total liabilities | 71,259,000 | 282,677,000 | 309,740,000 | 332,822,000 | 198,473,000 | 347,490,000 | 255,650,000 | 258,127,000 | 269,145,000 | 267,245,000 | 255,300,000 | 269,793,000 | 258,604,000 | 233,180,000 | 225,009,000 | 220,715,000 | 221,774,000 | 260,954,000 | 15,344,807 | 14,181,474 | 13,203,341 | 389,749 |
commitments and contingencies | ||||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||||
common stock, par value 0.0001... | 49,000 | 46,000 | 46,000 | 39,000 | 31,000 | 26,000 | 25,000 | 25,000 | 25,000 | 17,000 | 17,000 | 17,000 | 16,000 | 14,000 | 14,000 | 14,000 | 14,000 | 14,000 | ||||
additional paid-in capital | 1,713,437,000 | 1,534,792,000 | 1,527,239,000 | 1,186,256,000 | 888,608,000 | 625,130,000 | 618,256,000 | 610,395,000 | 604,384,000 | 303,428,000 | 297,218,000 | 291,933,000 | 282,573,000 | 272,528,000 | 272,406,000 | 270,184,000 | 257,602,000 | 253,744,000 | 7,388,136 | 5,646,714 | 24,105 | |
treasury stock | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | -57,350,000 | ||||||
accumulated deficit | -922,318,000 | -865,555,000 | -859,725,000 | -862,246,000 | -633,627,000 | -571,641,000 | -462,490,000 | -450,314,000 | -438,577,000 | -313,430,000 | -292,174,000 | -296,173,000 | -279,278,000 | -253,064,000 | -223,169,000 | -207,059,000 | -150,215,000 | -131,390,000 | -13,894,146 | -2,389,305 | -647,866 | -34,096 |
accumulated other comprehensive loss | -763,000 | -8,000 | ||||||||||||||||||||
total stockholders’ equity | 790,405,000 | 611,870,000 | 610,016,000 | 266,550,000 | 197,795,000 | -3,714,000 | 98,433,000 | 102,756,000 | 5,789,000 | 50,051,000 | 5,000,008 | 5,000,007 | ||||||||||
total liabilities and stockholders’ equity | 861,664,000 | 894,547,000 | 919,756,000 | 599,372,000 | 396,268,000 | 343,776,000 | 354,083,000 | 360,883,000 | 226,504,000 | 271,825,000 | ||||||||||||
short-term debt, including current portion of long-term debt | 16,560,000 | 367,000 | 818,000 | 818,000 | 417,000 | 826,000 | 1,229,000 | 522,000 | 1,296,000 | 2,059,000 | 769,000 | 1,921,000 | 3,074,000 | 4,233,000 | ||||||||
accumulated other comprehensive income | -63,000 | -194,000 | -149,000 | 133,000 | 121,000 | |||||||||||||||||
held-to-maturity investments, at amortized cost | 130,084,000 | |||||||||||||||||||||
deferred tax liabilities | 14,000 | 37,000 | 2,000 | 2,000 | 54,000 | 406,000 | 390,000 | 422,000 | 248,000 | |||||||||||||
liabilities and stockholders’ deficit | ||||||||||||||||||||||
deferred tax assets | 51,000 | 51,000 | ||||||||||||||||||||
other non-current liabilities | 10,000 | 36,000 | 136,000 | 343,000 | 324,000 | |||||||||||||||||
stockholders’ deficit: | ||||||||||||||||||||||
total stockholders’ deficit | 108,482,000 | -67,335,000 | -52,289,000 | -61,573,000 | -54,039,000 | -13,893,139 | -9,096 | |||||||||||||||
total liabilities and stockholders’ deficit | 377,627,000 | 199,910,000 | 203,011,000 | 208,220,000 | 204,565,000 | 380,653 | ||||||||||||||||
liabilities and stockholders deficit | ||||||||||||||||||||||
liabilities and equity | ||||||||||||||||||||||
stockholders’ (deficit) equity: | ||||||||||||||||||||||
total stockholders’ (deficit) equity | -37,872,000 | -8,099,000 | ||||||||||||||||||||
total liabilities and stockholders’ (deficit) equity | 195,308,000 | 216,910,000 | ||||||||||||||||||||
revenues | 155,011,000 | 40,651,000 | ||||||||||||||||||||
cost of revenues | 112,018,000 | 28,900,000 | ||||||||||||||||||||
gross margin | 42,993,000 | 11,751,000 | ||||||||||||||||||||
operating expenses: | ||||||||||||||||||||||
selling, general and administrative | 84,775,000 | 20,233,000 | ||||||||||||||||||||
research and development | 8,393,000 | 1,785,000 | ||||||||||||||||||||
restructuring charges | 4,203,000 | 1,562,000 | ||||||||||||||||||||
transaction expenses | 2,605,000 | 566,000 | ||||||||||||||||||||
goodwill impairment | 53,544,000 | |||||||||||||||||||||
operating income | -110,527,000 | -12,395,000 | ||||||||||||||||||||
interest expense | 14,436,000 | 3,557,000 | ||||||||||||||||||||
net increase in fair value of derivatives | -1,591,000 | |||||||||||||||||||||
loss on extinguishment of debt | ||||||||||||||||||||||
other income | 19,000 | 8,000 | ||||||||||||||||||||
income before taxes | -123,391,000 | -15,858,000 | ||||||||||||||||||||
income tax (benefit) expense | -1,717,000 | |||||||||||||||||||||
net income | -121,674,000 | -16,110,000 | ||||||||||||||||||||
basic net income per share | -950 | -130 | ||||||||||||||||||||
diluted net income per share | -950 | -130 | ||||||||||||||||||||
weighted-average shares outstanding: | ||||||||||||||||||||||
basic | 127,698,478,000 | 126,270,282,000 | ||||||||||||||||||||
diluted | 127,698,478,000 | 126,270,282,000 | ||||||||||||||||||||
net decrease in fair value of derivatives | -102,000 | |||||||||||||||||||||
income tax benefit | 252,000 | |||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||||
equity: | ||||||||||||||||||||||
total equity | 122,368,000 | |||||||||||||||||||||
total liabilities and equity | 383,322,000 | |||||||||||||||||||||
current assets | ||||||||||||||||||||||
cash | 982,249 | 1,651,632 | 2,172,952 | 150,000 | ||||||||||||||||||
prepaid expenses | 347,674 | 368,436 | 812,795 | |||||||||||||||||||
receivable from related party | 1,242 | 1,816 | ||||||||||||||||||||
cash and marketable securities held in trust account | 358,817,210 | 358,809,837 | 358,801,671 | |||||||||||||||||||
deferred offering costs | 230,653 | |||||||||||||||||||||
interest receivable on cash and marketable securities held in trust account | 2,950 | 1,278 | 3,250 | |||||||||||||||||||
other long-term assets | 114,487 | 194,363 | ||||||||||||||||||||
liabilities, redeemable common stock and stockholders’ deficit | ||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||
note payable to related parties | 125,000 | |||||||||||||||||||||
payable to related parties | 57,390 | 43,277 | 20,475 | 21 | ||||||||||||||||||
warrant liability | 384,881 | 417,870 | 210,025 | |||||||||||||||||||
deferred underwriting fee payable | 12,558,000 | 12,558,000 | 12,558,000 | |||||||||||||||||||
common stock subject to possible redemption, 35,880,000 shares as of september 30, 2021, at a redemption value of 10.00 per share | 358,814,144 | |||||||||||||||||||||
stockholders’ deficit | ||||||||||||||||||||||
preferred stock, par value of 0.0001 per share; 1,000,000 shares authorized; none issued or outstanding | ||||||||||||||||||||||
common stock | 1,007 | 1,177 | 1,159 | 895 | ||||||||||||||||||
total liabilities, redeemable common stock and stockholders’ deficit | 360,265,812 | |||||||||||||||||||||
liabilities, redeemable common stock and stockholders’ equity | ||||||||||||||||||||||
common stock subject to possible redemption, 34,184,588 shares as of june 30, 2021, at a redemption value of 10.00 per share | 341,845,880 | |||||||||||||||||||||
total liabilities, redeemable common stock and stockholders’ equity | 361,027,362 | 361,790,668 | ||||||||||||||||||||
common stock subject to possible redemption, 34,358,732 shares as of march 31, 2021, at a redemption value of 10.00 per share | 343,587,320 | |||||||||||||||||||||
commitments |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||
net loss | -56,763,000 | -5,830,000 | 2,521,000 | -228,619,000 | -61,986,000 | -146,487,000 | -12,176,000 | -11,737,000 | -125,147,000 | 3,999,000 | -16,895,000 | -26,214,000 | -16,110,000 | -56,844,000 | -18,825,000 | ||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||
depreciation and amortization expense | 7,081,000 | 4,233,000 | 4,127,000 | 3,451,000 | 3,470,000 | 3,133,000 | 3,394,000 | 2,907,000 | 2,439,000 | 1,971,000 | 1,979,000 | 1,986,000 | 1,994,000 | 2,038,000 | 1,954,000 | 1,772,000 | |||||
amortization of debt discount and issuance costs | 41,000 | 2,108,000 | |||||||||||||||||||
accretion of discount on investments in debt securities | -381,000 | ||||||||||||||||||||
equity-based compensation expense | 3,423,000 | 6,290,000 | 5,321,000 | 4,319,000 | 7,400,000 | 5,053,000 | 5,168,000 | 5,749,000 | 5,157,000 | 4,793,000 | 3,994,000 | 3,805,000 | -295,000 | 2,222,000 | 5,080,000 | 3,858,000 | |||||
non-cash lease expense | 233,000 | 246,000 | 1,330,000 | 254,000 | 370,000 | 167,000 | 190,000 | 269,000 | 94,000 | 153,000 | 332,000 | -35,000 | |||||||||
provision for doubtful accounts | 0 | 0 | 311,000 | 40,000 | 8,000 | 44,000 | 5,000 | 171,000 | 50,000 | 675,000 | 882,000 | 11,000 | |||||||||
loss on extinguishment of debt | 15,826,000 | 0 | 0 | 0 | 2,577,000 | ||||||||||||||||
increase in fair value of derivatives | 20,125,000 | -50,168,000 | -26,125,000 | ||||||||||||||||||
changes in assets and liabilities: | |||||||||||||||||||||
decrease in accounts receivable | -660,000 | 2,998,000 | 3,972,000 | 5,919,000 | 4,348,000 | -4,266,000 | -3,469,000 | -3,117,000 | -1,223,000 | 1,981,000 | |||||||||||
decrease in contract assets | -656,000 | 1,962,000 | -1,479,000 | -189,000 | 383,000 | 849,000 | -703,000 | 1,338,000 | 2,443,000 | -106,000 | 2,080,000 | -2,306,000 | |||||||||
(increase) in prepaid expenses and other assets | -339,000 | ||||||||||||||||||||
decrease in accounts payable | -1,984,000 | -2,809,000 | 2,150,000 | -876,000 | -4,163,000 | -3,177,000 | |||||||||||||||
increase in accrued expenses | -534,000 | -6,768,000 | 1,749,000 | 319,000 | 4,446,000 | ||||||||||||||||
increase in contract liabilities | -3,450,000 | -373,000 | -959,000 | 1,449,000 | 476,000 | 28,000 | -983,000 | -357,000 | 1,826,000 | 325,000 | -2,736,000 | 1,044,000 | -633,000 | -1,415,000 | |||||||
increase in other liabilities | 37,000 | 2,607,000 | -1,680,000 | 178,000 | 1,670,000 | 551,000 | -728,000 | -1,115,000 | 49,000 | 450,000 | 1,422,000 | 255,000 | 83,000 | ||||||||
net cash from operating activities | -18,001,000 | -21,834,000 | -9,585,000 | -3,868,000 | -6,664,000 | -14,806,000 | -1,896,000 | -7,058,000 | -14,359,000 | 18,214,693 | 6,580,000 | -12,796,000 | -12,017,000 | -10,528,000 | -6,394,000 | -24,467,000 | -7,529,000 | -17,513,148 | -669,383 | -521,320 | -1,078,149 |
cash flows from investing activities: | |||||||||||||||||||||
proceeds from maturities of investments in debt securities | 43,225,000 | ||||||||||||||||||||
acquisition of businesses, net of cash acquired | -10,183,000 | 0 | -89,000 | ||||||||||||||||||
purchases of property and equipment | -319,000 | -252,000 | -188,000 | -5,000 | -80,000 | -180,000 | -137,000 | -129,000 | -38,000 | 0 | -33,000 | -228,000 | -149,000 | -359,000 | |||||||
capitalized software development costs | 0 | -1,142,000 | -1,159,000 | -1,540,000 | -3,234,000 | -4,171,000 | -1,582,000 | -1,643,000 | |||||||||||||
net cash from investing activities | 32,723,000 | -343,829,000 | -260,069,000 | -1,164,000 | -1,620,000 | -3,414,000 | -4,308,000 | -1,711,000 | 12,254,000 | 2,742,170 | -2,744,000 | -33,000 | -317,000 | -4,525,000 | -359,000 | 0 | 0 | -358,800,000 | |||
cash flows from financing activities: | |||||||||||||||||||||
proceeds from issuance of shares for exercised rdo and pipe warrants | 0 | 0 | 0 | 64,673,000 | 0 | 0 | 0 | 53,809,000 | |||||||||||||
payment of private placement and registered direct offering transaction costs | -499,000 | ||||||||||||||||||||
repayment of short-term borrowings | 0 | -367,000 | -85,000 | -366,000 | 0 | -417,000 | -409,000 | -403,000 | -522,000 | -774,000 | -763,000 | -769,000 | -1,152,000 | -1,153,000 | -1,159,000 | ||||||
proceeds from at-the-market offering | 293,431,000 | 6,569,000 | |||||||||||||||||||
payment of transaction costs for at-the-market offering | -5,135,000 | -115,000 | |||||||||||||||||||
payment of debt issuance costs to third parties | 0 | 0 | -337,000 | -4,342,000 | |||||||||||||||||
proceeds from exercise of options | 67,000 | 61,000 | 1,971,000 | 240,000 | 1,393,000 | 302,000 | 0 | 33,000 | 86,000 | ||||||||||||
payments of tax withholding from the issuance of common stock | -850,000 | -108,000 | -358,000 | -361,000 | -1,318,000 | 765,000 | -3,000 | -608,000 | -2,532,000 | ||||||||||||
net cash from financing activities | -783,000 | 1,263,000 | 335,285,000 | 288,822,000 | 65,943,000 | 2,295,000 | -420,000 | -377,000 | 50,960,000 | -40,488,938 | -1,575,000 | 20,894,000 | 21,212,000 | 1,238,000 | -1,163,000 | -1,157,000 | -102,055,000 | 0 | 0 | 361,901,101 | |
effect of foreign currency rate changes on cash, cash equivalents, and restricted cash | 120,000 | ||||||||||||||||||||
net increase in cash, cash equivalents, and restricted cash | 14,059,000 | ||||||||||||||||||||
cash, cash equivalents, and restricted cash at the beginning of the period | 92,647,000 | ||||||||||||||||||||
cash, cash equivalents, and restricted cash at the end of the period | 106,706,000 | ||||||||||||||||||||
supplemental schedule of non-cash investing and financing activities: | |||||||||||||||||||||
issuance of common stock upon conversion of 2029 notes | 233,358,000 | 0 | 0 | 135,597,000 | |||||||||||||||||
issuance of common stock for paid-in-kind interest on 2029 convertible notes | |||||||||||||||||||||
issuance of common stock for exercise of rdo and pipe warrants, net of cash received | |||||||||||||||||||||
reconciliation of cash, cash equivalents, and restricted cash: | |||||||||||||||||||||
cash and cash equivalents | 100,704,000 | -7,874,000 | -30,149,000 | 59,978,000 | |||||||||||||||||
restricted cash | 6,002,000 | ||||||||||||||||||||
goodwill impairment | 0 | 0 | 0 | 0 | 0 | 85,000,000 | 18,292,000 | 0 | |||||||||||||
impairment of long-lived assets | |||||||||||||||||||||
deferred income tax benefit | |||||||||||||||||||||
loss on sale of property and equipment | 2,000 | 0 | 8,000 | ||||||||||||||||||
decrease in prepaid expenses and other assets | -7,232,000 | -2,546,000 | 1,203,000 | -1,795,000 | 536,000 | 297,000 | 293,000 | 950,000 | 937,000 | 3,756,000 | 1,488,000 | 3,014,000 | 103,000 | 432,000 | |||||||
purchases of investments in debt securities | |||||||||||||||||||||
proceeds from maturities and sales of investments in debt securities | |||||||||||||||||||||
acquisition of business, net of cash acquired | 0 | 0 | 0 | 13,935,000 | |||||||||||||||||
proceeds from issuance of private placement and registered direct offering shares | |||||||||||||||||||||
proceeds from short-term borrowings | |||||||||||||||||||||
issuance of common stock upon espp purchase | 1,310,000 | 0 | 760,000 | 0 | |||||||||||||||||
amortization of discount on htm investments | |||||||||||||||||||||
purchases of htm investments | |||||||||||||||||||||
payment of rdo and pipe transaction costs | 0 | 0 | -551,000 | ||||||||||||||||||
proceeds from at-the-market offerings | |||||||||||||||||||||
payment of transaction costs for at-the-market offerings | |||||||||||||||||||||
effect of foreign currency rate changes on cash and cash equivalents | 104,000 | -555,000 | -190,000 | 482,000 | |||||||||||||||||
net increase in cash and cash equivalents | 65,735,000 | 283,235,000 | 57,469,000 | -15,443,000 | -6,682,000 | -9,146,000 | 48,855,000 | ||||||||||||||
cash and cash equivalents at the beginning of the period | |||||||||||||||||||||
cash and cash equivalents at the end of the period | 65,735,000 | 283,235,000 | 107,610,000 | -15,443,000 | -6,682,000 | -9,146,000 | 81,412,000 | ||||||||||||||
issuance of shares for paid-in-kind interest on 2029 convertible notes | 0 | ||||||||||||||||||||
issuance of common stock as consideration for the acquisition of pangiam | |||||||||||||||||||||
amortization of debt issuance costs and discount | 2,026,000 | 2,764,000 | |||||||||||||||||||
cash and cash equivalents at the beginning of period | 0 | 50,141,000 | 0 | 0 | 0 | 32,557,000 | |||||||||||||||
cash paid during the period for: | |||||||||||||||||||||
interest | |||||||||||||||||||||
income taxes | |||||||||||||||||||||
net increase in fair value of derivatives | 33,336,000 | 92,826,000 | -1,278,000 | -7,882,000 | 23,992,000 | 3,121,000 | 10,567,000 | ||||||||||||||
issuance of common stock as consideration for pangiam acquisition | 2,987,000 | -6,000 | 207,776,000 | ||||||||||||||||||
impairment of right-of-use assets | |||||||||||||||||||||
increase in accounts payable | 1,778,000 | -3,210,000 | -4,914,000 | 7,996,000 | 1,072,000 | -276,000 | 1,150,000 | ||||||||||||||
increase in accrued liabilities | -10,483,000 | 5,958,000 | -947,000 | 2,599,000 | 1,375,000 | -3,406,000 | 4,066,000 | -4,128,000 | 1,516,000 | -8,816,000 | 6,307,000 | ||||||||||
repurchase of shares as a result of forward share purchase agreements | 0 | 0 | 0 | -100,896,000 | |||||||||||||||||
amortization of debt issuance costs | 505,000 | 506,000 | 506,000 | 506,000 | 506,000 | 500,000 | 732,000 | 523,000 | 524,000 | 523,000 | |||||||||||
deferred income tax expense | 0 | -14,000 | -23,000 | 0 | -1,000 | 54,000 | -1,768,000 | 174,000 | |||||||||||||
increase in accounts receivable | 836,000 | ||||||||||||||||||||
decrease in other liabilities | 29,000 | ||||||||||||||||||||
(increase) in accounts receivable | -8,957,000 | ||||||||||||||||||||
(decrease) in accounts payable | -5,960,000 | ||||||||||||||||||||
proceeds from issuance of private placement shares | 21,975,000 | ||||||||||||||||||||
payment of private placement transaction costs | |||||||||||||||||||||
net increase in cash and cash equivalents and restricted cash | -19,532,075 | 2,261,000 | 8,096,000 | 9,195,000 | -9,323,000 | -109,943,000 | |||||||||||||||
cash and cash equivalents and restricted cash at the beginning of period | -12,619,368 | 0 | 0 | 12,632,000 | 0 | 0 | 0 | 169,921,000 | |||||||||||||
cash and cash equivalents and restricted cash at the end of the period | -32,151,443 | 2,261,000 | 8,096,000 | 21,827,000 | -9,323,000 | -7,874,000 | -30,149,000 | 59,978,000 | |||||||||||||
net decrease in fair value of derivatives | -102,000 | -199,000 | -1,263,000 | ||||||||||||||||||
proceeds from issuance of private placement shares and registered direct offering shares | 0 | ||||||||||||||||||||
repurchase of shares as a result of forward purchase agreements | |||||||||||||||||||||
payments for taxes related to net share settlement of equity awards | -1,085,000 | -52,000 | -11,000 | ||||||||||||||||||
issuance of common stock as consideration for the acquisition of promodel corporation | 0 | ||||||||||||||||||||
decrease in contract liabilities | |||||||||||||||||||||
increase in contract assets | -1,115,000 | 11,000 | |||||||||||||||||||
net income | -1,924,883 | -1,741,439 | -613,770 | ||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
benefit from doubtful accounts | |||||||||||||||||||||
deferred income tax (benefit) expense | |||||||||||||||||||||
increase in prepaid expenses and other assets | |||||||||||||||||||||
proceeds from disposal of property and equipment | |||||||||||||||||||||
proceeds from term loan | |||||||||||||||||||||
repayment of term loan | |||||||||||||||||||||
proceeds from promissory notes | |||||||||||||||||||||
repayment of promissory notes | |||||||||||||||||||||
proceeds from issuance of convertible notes | |||||||||||||||||||||
proceeds from the merger | |||||||||||||||||||||
payment of merger transaction costs | |||||||||||||||||||||
distributions to members | |||||||||||||||||||||
parent’s contribution | |||||||||||||||||||||
reconciliation of cash and cash equivalents and restricted cash: | |||||||||||||||||||||
cash and cash equivalents and restricted cash at end of the period | -7,874,000 | -30,149,000 | 59,978,000 | ||||||||||||||||||
net decrease in cash and cash equivalents and restricted cash | |||||||||||||||||||||
capital expenditures | -252,000 | -1,330,000 | -1,164,000 | -1,620,000 | -3,414,000 | -4,308,000 | -1,711,000 | -1,681,000 | 0 | 0 | 0 | -33,000 | -228,000 | -149,000 | -359,000 | 0 | 0 | 0 | 0 | ||
free cash flows | -22,086,000 | -10,915,000 | -5,032,000 | -8,284,000 | -18,220,000 | -6,204,000 | -8,769,000 | -16,040,000 | 18,214,693 | 6,580,000 | -12,796,000 | -10,561,000 | -6,622,000 | -24,616,000 | -7,888,000 | -17,513,148 | -669,383 | -521,320 | -1,078,149 | ||
free cash flow | |||||||||||||||||||||
free cash flow from acquired businesses | |||||||||||||||||||||
operating cash flow from acquired businesses | |||||||||||||||||||||
capital expenditures of acquired businesses | |||||||||||||||||||||
pro forma free cash flow | |||||||||||||||||||||
funded | |||||||||||||||||||||
unfunded | |||||||||||||||||||||
priced, unexercised options | |||||||||||||||||||||
unpriced, unexercised options | |||||||||||||||||||||
anticipated follow-on awards | |||||||||||||||||||||
total backlog | |||||||||||||||||||||
operating activities | |||||||||||||||||||||
change in fair value of warrant liability | -32,989 | 207,845 | 22,117 | ||||||||||||||||||
interest earned on cash and marketable securities held in trust account | -9,045 | -6,194 | -4,921 | ||||||||||||||||||
change in operating assets and liabilities: | |||||||||||||||||||||
prepaid expenses | 20,762 | ||||||||||||||||||||
receivable from related party | 574 | ||||||||||||||||||||
other long-term assets | 79,876 | ||||||||||||||||||||
accounts payable | -8,122 | -16,035 | 26,553 | ||||||||||||||||||
payable to related parties | 14,113 | 22,802 | 20,454 | ||||||||||||||||||
accrued liabilities | 1,187,632 | 761,672 | 282,745 | ||||||||||||||||||
other current liabilities | 2,699 | 1,849 | 1,468 | ||||||||||||||||||
investing activities | |||||||||||||||||||||
investment of cash in trust account | 0 | 0 | -358,800,000 | ||||||||||||||||||
financing activities | |||||||||||||||||||||
proceeds from sale of units, net of underwriting discounts paid | 0 | 0 | 351,624,000 | ||||||||||||||||||
proceeds from sale of private placement units to founder | 0 | 0 | 8,500,000 | ||||||||||||||||||
proceeds from sale of private placement units to underwriters | 0 | 0 | 2,496,000 | ||||||||||||||||||
repayment of borrowing from a related party | 0 | 0 | -125,000 | ||||||||||||||||||
payment of offering costs | 0 | 0 | -593,899 | ||||||||||||||||||
net increase in cash during period | -669,383 | -521,320 | 2,022,952 | ||||||||||||||||||
cash, beginning of period | 0 | 0 | 150,000 | ||||||||||||||||||
cash, end of period | -669,383 | -521,320 | 2,172,952 | ||||||||||||||||||
supplemental disclosure of non-cash financing activities | |||||||||||||||||||||
offering costs included in accrued liabilities | 0 | 0 | 70,000 | ||||||||||||||||||
fair value of warrant liability | 0 | 0 | 187,908 | ||||||||||||||||||
deferred underwriting fee payable | 0 | 0 | 12,558,000 | ||||||||||||||||||
change in value of common stock subject to possible redemption | 16,968,264 | -1,741,440 | 5,185,219 | ||||||||||||||||||
common stock subject to possible redemption | |||||||||||||||||||||
numerator: earnings allocable to common stock subject to redemption | |||||||||||||||||||||
interest earned on marketable securities held in trust account, net of taxes | |||||||||||||||||||||
net income attributable to common stock subject to possible redemption | |||||||||||||||||||||
denominator: weighted-average common shares subject to redemption | |||||||||||||||||||||
basic and diluted weighted-average shares outstanding, common stock subject to possible redemption | |||||||||||||||||||||
basic and diluted net income per share, common stock subject to possible redemption | |||||||||||||||||||||
non-redeemable common stock | |||||||||||||||||||||
numerator: net income minus net earnings - basic and diluted | |||||||||||||||||||||
less: net income attributable to common stock subject to redemption | -3,114 | -650 | -2,582 | ||||||||||||||||||
net income attributable to non-redeemable common stock | |||||||||||||||||||||
denominator: weighted-average non-redeemable common shares | |||||||||||||||||||||
weighted-average non-redeemable common shares outstanding, basic and diluted | |||||||||||||||||||||
net income per share | -0.04 | -0.09 | -0.06 | ||||||||||||||||||
net income attributable to common stockholders | -1,128,319 | -616,352 | |||||||||||||||||||
weighted-average common shares outstanding, basic and diluted | 1,287,326 | 10,375,485 | |||||||||||||||||||
prepaid and other current assets | -812,795 | ||||||||||||||||||||
proceeds from sale of common stock to founder | |||||||||||||||||||||
proceeds from related party loan | |||||||||||||||||||||
deferred offering costs included in accounts payable | |||||||||||||||||||||
deferred offering costs included in accrued liabilities | |||||||||||||||||||||
level 1: |